The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Sales well up, but profits down (global cost headwinds). Outlook remains excellent. Share price on the Dhaka stock exchange down just 0.34% (hardly changed) at Taka 146.20 , which translates into 111.1 pence, which is well more than twice the price of our non-voting shares (with precisely the same protected Dividend rights),
Certainly a long term hold for me.
There would be a major problem if the block-tenants cannot pay the rent - due to whatever macro economic circumstances (e.g energy costs, high repair/maintenance costs).
What would the appartments be worth with sitting tentants and rents unpaid. Current book values will then look absurdly high. Hopefully things are not quite that bad, but there is some smoke....,. j
Market Cap at current share price (51p) is now less than half the company's Net Assets - (property value minus debt).
Can the share price realistically still go down further? I cannot help but think that at 51p we must have reached the bottom.
Little steps up from here could reasonably be expected....
IMHO
JOLLY - Dividend yield of 4% or more is mighty good from a fast growing pharmaceutical company with expanding global reach. Bangladesh based investors with voting shares receive exlactly the same dividend, but pay twice the price for their shares,
Imagine GSK or BP non-voting shares with protected full dividend rights at at half price.... would you pounce or wait to buy ....?!
Jolly - Great thiings will indeed come to those who buy now at current low price (arouind 50p) and wait patiently.
Best fill your boots whilst the price is still so remarkably - unjustified - low.
My boots are ful.
Bezza - BDT 13.7 = GBP 10.7p at current exchange rate.
Pretty good though: Earnings Per Share 10.7p for shares priced at around 50p at curremnt low trading price.
Mind you, our correspondent Jolly would not want to buy the shares at current half price, he is more interested
in voting rights. Very few private investors are interested in voting.
I never, ever vote., I leave it to the major shareholders
Pedro - Well said, I could not add more to that, the BXP shares here are at bargain basement bottom price, time to buy is now ratjher than wait for the rise which inevitably will come in the not too distant future. The gap between the price hire and the price in Dhaka is absolutely bound to narrow over time. So dividends, plus narrowing price gap, what's not to like.
Jolly is deperate to see the share price down further, he want to wade in in at the lowest possible price, which - he is yet to realise - is alrealdy there, right now. So Jolly, stop spouting bullsh.t, wade in now, you are not yet too late.
Jolly - We live inthe present, forget about the past.
BXP is a globally respected company, the shares here at less than half price of the shares on the Dhaka stock exchange,
are at bargain basement level, dirt cheap.
Jolly - I am sorry to have to say that you are talking nonsence (your message 9.27am). You try to sound like an expert, but seemingly you are not. Your efferots to try to talk the share price down are now blatantly obvious.
Jolly - I thought you were wiser than that. Whatever you say, voting rightS have no value to private investors, no value whatsoever. Divident Rights, that is what the shares are about - and our Dividend Rights are precisely the same as those for the shareholdders in Bangladesh (WHO PAY TWICE THE PRICE FOR THEIR SHARES) . There simply cannot be a corporate arrangements that awards one mote than the other. The price gap will very much narrow over time, meanwhile we enjoy the worthwhilen and wellcome Dividend whilst in due course, over time, WE also will benfefit from a rising price towards narrowing the price gap. BXP is not a fly by night Company, but a highly respected Compnay with growing global reach.
AT 50P THE SHARES HERE ARE A SNIP.